United States:
Healthcare & Life Sciences Private Equity Deal Tracker: Surge Invests In Elite Clinical Network
20 September 2023
McGuireWoods LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Surge Private Equity has announced it has invested in Elite Clinical
Network (ECN) in a transaction valued at around $200 million.
ECN, founded in 2003 and based in Las Vegas, is
a network of pharmaceutical research sites throughout California,
Arizona and Nevada.
Surge, based
in Dallas, is lower middle market equity firm pursuing investments
in healthcare and a few other industries. Founded in 2017, the firm
seeks majority investments in businesses with between $3 million
and $30 million of EBITDA.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Trends & Transactions Q3 2023
Bass, Berry & Sims
After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year.
Telehealth Providers: HHS Issues HIPAA Best Practices
Foley & Lardner
Recognizing the evolving landscape of care delivery and growth of telehealth, the U.S. Department of Health and Human Services (HHS)published a resource guide aimed at assisting telehealth providers...